Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Mucosal Immunology

Volumn 9, Issue 6, 2016, Pages 1455-1465

  Jorgensen S F ^a,b,c,d   Troseid M ^a,b,c   Kummen, M ^a,b,c,d   Anmarkrud, J A ^a,b   Michelsen, A E ^a,d   Osnes, L T ^e   Holm, K ^a,b   Hoivik M L ^f   Rashidi, A ^a   Dahl, C P ^a,b   Vesterhus, M ^b,g   Halvorsen, B ^a,c,d   Mollnes, T E ^c,e,h,i,j   Berge, R K ^g,k   Moum, B ^d,f   Lundin, K E A ^b,d   Fevang, B ^a,b,d   Ueland, T ^b,c,d,i   Karlsen, T H ^a,b,c,d,k   Aukrust, P ^a,b,c,d   Hov, J R ^a,b,c,d   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^h NORDLAND HOSPITAL   (Norway)

ⁱ UNIVERSITY OF TROMSØ   (Norway)

^j NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^k UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD14 ANTIGEN; IMMUNOGLOBULIN A; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; RNA 16S; BIOLOGICAL MARKER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD ANALYSIS; CELL ACTIVATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSBIOSIS; FECES ANALYSIS; FEMALE; HUMAN; IMMUNE ACIVATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MALE; MICROBIAL DIVERSITY; POPULATION ABUNDANCE; PRIORITY JOURNAL; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION; TAXONOMIC IDENTIFICATION; ADOLESCENT; AGED; BIODIVERSITY; CASE CONTROL STUDY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; T LYMPHOCYTE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIODIVERSITY; BIOMARKERS; CASE-CONTROL STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84991677429     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.18     Document Type: Article

References (48)

1. Yong, P.F., Thaventhiran, J.E., & Grimbacher, B. A rose is a rose is a rose, but CVID is Not CVID common variable immune deficiency CVID), what do we know in 2011? Adv Immunol. 111, 47-107 (2011
2. Aukrust, P., Muller, F., & Froland, S.S. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin. Immunol. Immunopathol. 70, 217-224 (1994
3. Aukrust, P., Muller, F., & Froland, S.S. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin. Exp. Immunol. 97, 232-238 (1994
4. Aukrust, P., Svardal, A.M., Muller, F., Lunden, B., Berge, R.K., & Froland, S.S. Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress. Blood 86, 1383-1391 (1995
5. Resnick, E.S., Moshier, E.L., Godbold, J.H., & Cunningham-Rundles, C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119, 1650-1657 (2012
6. Chapel,H., Lucas, M., Lee,M., Bjorkander, J.,Webster, D., &Grimbacher, B. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112, 277-286 (2008
7. Chapel, H., & Cunningham-Rundles, C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br. J. Haematol. 145, 709-727 (2009
8. Salzer, U.,Warnatz, K., & Peter, H.H. Common variable immunodeficiency - An update. Arthritis Res. Ther. 14, 223 (2012
9. Li, J., Jorgensen, S.F., Maggadottir, S.M., Bakay, M., Warnatz, K., & Glessner, J. Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat. Commun. 6, 6804 (2015
10. Maggadottir, S.M., Li, J., Glessner, J.T., Li, Y.R., Wei, Z., & Chang, X. Rare variants at 16p11. 2 are associated with common variable immunodeficiency. J. Allergy Clin. Immunol. 135, 1569-1577 (2015
11. Fagarasan, S., Kawamoto, S., Kanagawa, O., & Suzuki, K. Adaptive immune regulation in the gut: Tcell-dependent and Tcell-independent IgA synthesis. Annu. Rev. Immunol. 28, 243-273 (2010
12. Geuking, M.B., Cahenzli, J., Lawson, M.A., Ng, D.C., Slack, E., & Hapfelmeier, S. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34, 794-806 (2011
13. Hooper, L.V., Littman, D.R., & Macpherson, A.J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012
14. Sutherland, D.B., & Fagarasan, S. IgA synthesis: a form of functional immune adaptation extending beyond gut. Curr. Opin. Immunol. 24, 261-268 (2012
15. Lorenz, R.G., Chaplin, D.D., McDonald, K.G., McDonough, J.S., & Newberry, R.D. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin b receptor, and TNF receptor I function. J. Immunol. 170, 5475-5482 (2003
16. Tremaroli, V., & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012
17. Ley, R.E., Turnbaugh, P.J., Klein, S., & Gordon, J.I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006
18. Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., & Bartelsman, J.F. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-6 e7 (2012
19. De Vos,W.M., & De Vos, E.A. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 70 (Suppl 1), S45-S56 (2012
20. Shulzhenko, N., Morgun, A., Hsiao,W., Battle, M., Yao, M., & Gavrilova, O. Crosstalk between Blymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585-1593 (2011
21. Perreau, M., Vigano, S., Bellanger, F., Pellaton, C., Buss, G., & Comte, D. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J. Exp. Med. 211, 2033-2045 (2014
22. Kawamoto, S., Maruya, M., Kato, L.M., Suda, W., Atarashi, K., & Doi, Y. Foxp3(+) T Cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41, 152-165 (2014
23. Gevers, D., Kugathasan, S., Denson Lee, A., Vázquez-Baeza, Y., Van Treuren, W., & Ren, B. The treatment-naive microbiome in new-onset Crohn's disease. Cell. Host. Microbe. 15, 382-392 (2014
24. Segata,N., Izard, J.,Waldron, L.,Gevers, D.,Miropolsky, L., & Garrett,W.S. Metagenomic biomarker discovery and explanation.Genome Biol 2011 12 R60
25. Giovannetti, A., Pierdominici, M., Mazzetta, F., Marziali, M., Renzi, C., & Mileo, A.M. Unravelling the complexity of T cell abnormalities in ;common variable immunodeficiency. J. Immunol. 178, 3932-3943 (2007
26. Mouillot, G., Carmagnat, M., Gerard, L., Garnier, J.L., Fieschi, C., & Vince, N. B-Cell and T-Cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J. Clin. Immunol. 30, 746-755 (2010
27. Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., & Broadhurst, M.J. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra91 (2013
28. Garrett,W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., & Ito, S. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007
29. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., & Booth, C.J. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011
30. Vijay-Kumar,M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., & Srinivasan, S. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010
31. Croker, B.A., Lawson, B.R., Rutschmann, S., Berger,M., Eidenschenk, C., & Blasius, A.L. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1,MyD88, and amicrobial trigger. Proc. Natl Acad. Sci. USA 105, 15028-15033 (2008
32. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., & Strowig, T. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012
33. Ventura, M., Turroni, F., Lugli, G.A., & Van Sinderen, D. Bifidobacteria and humans: our special friends, from ecological to genomics perspectives. J. Sci. Food Agric. 94, 163-168 (2014
34. Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., & Rao, S. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006
35. Sandek, A., Bjarnason, I., Volk, H.D., Crane, R., Meddings, J.B., & Niebauer, J. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int. J. Cardiol. 157, 80-85 (2012
36. Cani, P.D., Possemiers, S., Van De Wiele, T., Guiot, Y., Everard, A., & Rottier, O. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103 (2009
37. Nowak, P., Troseid, M., Avershina, E., Barqasho, B., Neogi, U., & Holm, K. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 29, 2409-2418 (2015
38. Cunningham-Rundles, C. The many faces of common variable immunodeficiency. Hematology 2012, 301-305 (2012
39. Dethlefsen, L., Huse, S., Sogin, M.L., & Relman, D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6, e280 (2008
40. Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., & Brown, P.O. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177 (2007
41. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., & Knight, R. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl Acad. Sci. USA 108 (Suppl 1), 4578-4585 (2011
42. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., & Kau, A.L. Gut microbiota from twins discordant for obesity modulate metabolism inmice. Science 341, 1241214 (2013
43. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin. Exp. Immunol. 118 Suppl 1, 1-28 (1999
44. Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., & Cunningham-Rundles, C. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol. 5, 162 (2014
45. Ahlquist, D.A., Schwartz, S., Isaacson, J., & Ellefson, M. A stool collection device: the first step in occult blood testing. Ann. Intern. Med. 108, 609-612 (1988
46. Wu, G.D., Lewis, J.D., Hoffmann, C., Chen, Y.Y., Knight, R., & Bittinger, K. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16 Suence tags. BMC Microbiol 206 2010
47. Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K., & Schloss, P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112-5120 (2013
48. Wehr, C., Kivioja, T., Schmitt, C., Ferry, B., Witte, T., & Eren, E. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111, 77-85 (2008